New study aims to catch silent lung threat in scleroderma
NCT ID NCT07186439
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study will screen 35 adults with scleroderma for pulmonary hypertension using echocardiography. The goal is to see how often this serious lung condition occurs in these patients. The study is not yet recruiting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this screening method could help detect dangerous lung complications early in scleroderma patients.
- What could go wrong
- This is a small, early-stage screening study with only 35 participants. It may not prove that screening improves outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHTN IN SCLERODERMA PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a skin patch ease stomach pain in scleroderma?
- Blood thinner may stop autoimmune disease before it starts
- Can online therapy help scleroderma patients manage daily life?
- Pandemic stress hits hard for arthritis patients
- New shot aims to tame rare autoimmune disease
- Could weak legs be making it hard to breathe? new study investigates